Sentences with phrase «clinical vaccine research»

Boston, MA About Blog The Center for Virology and Vaccine Research (CVVR) at Beth Israel Deaconess Medical Center aims to promote research and education activities related to virology, translational, and clinical vaccine research.

Boston, MA About Blog The Center for Virology and Vaccine Research (CVVR) at Beth Israel Deaconess Medical Center aims to promote research and education activities related to virology, translational, and clinical vaccine research.

Boston, MA About Blog The Center for Virology and Vaccine Research (CVVR) at Beth Israel Deaconess Medical Center aims to promote research and education activities related to virology, translational, and clinical vaccine research.

Boston, MA About Blog The Center for Virology and Vaccine Research (CVVR) at Beth Israel Deaconess Medical Center aims to promote research and education activities related to virology, translational, and clinical vaccine research.

Comparable antigenicity and immunogenicity of oligomeric forms of a novel, acute HIV - 1 subtype C gp145 envelope for use in preclinical and clinical vaccine research, doi: 10.1128 / JVI.00412 - 15, J Virol.

Not exact matches

The Albert and Mary Lasker Foundation announced yesterday that it was presenting its prestigious 2017 Lasker - DeBakey Clinical Medical Research Award to a pair of National Cancer Institute researchers, Douglas Lowy and John Schiller, who created a vaccine to prevent human papilloma virus, or HPV, from taking hold in the body.

In September, an international research team published much - awaited results of a clinical trial for the vaccine.

Orme and his research team in Fort Collins investigated whether the existing vaccine for TB, which goes by the acronym BCG (bacille Calmette - Guerin), worked equally well against different clinical strains of tuberculosis.

But research published in this month's issue of the Journal of Clinical Investigation shows that newborn mice, instead of being immunized to the protein encoded by a DNA vaccine, actually learn to tolerate it.

«Today we see more opportunity than ever to be gained from investing in vaccine research,» says Keith Gottesdiener, vice president for vaccine and infectious disease clinical research with Merck.

Koff says the next milestone will be later stage clinical testing of a vaccine developed by the federally funded National Institutes of Health Vaccine Research Center, which should begin nexvaccine developed by the federally funded National Institutes of Health Vaccine Research Center, which should begin nexVaccine Research Center, which should begin next year.

His laboratory research has focused on developing a vaccine that targets the bacterium Staphylococcus aureus and the fungus Candida; the vaccine is undergoing clinical development.

«We are pleased to have demonstrated such a potent and durable immune response to the vaccine,» said the study's lead author, Sita Awasthi, PhD, a research associate professor of Infectious Diseases at Penn. «If found effective in clinical trials, the vaccine will have a huge impact on reducing the overall prevalence of genital herpes infections and could reduce new HIV infections as well, especially in high - burden regions of sub-Saharan Africa.»

The German biotech CureVac, for example, has brought mRNA - based vaccines for rabies and cancer to clinical trials, and Karikó now heads a research team at BioNTech in Mainz, Germany, that focuses on mRNA - based drugs.

What most encourages Black, in addition to the new breakthrough in blood - brain barrier research, are the results of a Phase 1 clinical trial of an anticancer vaccine that began at the institute in 1998.

Dr. Michael's research interests include HIV molecular pathogenesis and host genetics, HIV clinical research, and HIV vaccine development.

President Barack Obama gave a talk at the NIH Clinical Center and then toured the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center.

«The pace of preclinical and early clinical development for Zika vaccines is unprecedented,» said Barouch, corresponding author and director of the Center for Virology and Vaccine Research at BIDMC.

The NIH formed its own HIV vaccine trial network in 2000 to oversee clinical research sites in the U.S., Africa, Asia, the Caribbean and South America.

But since a substantial part of the harmful effects of Zika virus infection may occur in the early part of pregnancy, administering vaccines prior to pregnancy or early in pregnancy may be most beneficial, and more clinical research is needed for this time period.

The Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act were enacted to address the lack of information available to prevent and treat disease in children, and similar legislation could foster more research in pregnancy and pre-pregnancy and overcome the barriers to better vaccines and more effective clinical prResearch Equity Act were enacted to address the lack of information available to prevent and treat disease in children, and similar legislation could foster more research in pregnancy and pre-pregnancy and overcome the barriers to better vaccines and more effective clinical prresearch in pregnancy and pre-pregnancy and overcome the barriers to better vaccines and more effective clinical practices.

The second phase of clinical trials of the vaccine are underway in Brazil, conducted by Orygen Biotecnologia SA, and the Infectious Disease Research Institute, Seattle.

«Frankly, if we had not gone through our 10 - year slide in research support, we probably would have had a vaccine in time for this that would've gone through clinical trials and would have been ready.»

As VRC Director, Dr. Mascola provides scientific leadership to the basic, clinical, and translational research activities of the VRC; develops vaccine research programs to meet public health needs; allocates VRC resources; and develops policies for the execution of multi-disciplinary research.

Concepts of how to apply vaccines as part of cancer treatment or as prevention of recurrence, are moving vaccines from being considered a secondary player in cancer clinical management to vaccine approaches gravitating towards becoming a central plank in the newest area of cancer therapy research.

A major theme is translational research involving the rapid early - stage development and assessment of new vaccines in clinical trials.

PHILADELPHIA --(April 19, 2018)-- The Wistar Institute and partners at the Perelman School of Medicine at the University of Pennsylvania, Inovio Pharmaceuticals, and GeneOne Life Science were recognized among the Top 10 Clinical Research Achievement Awards by the Clinical Research Forum for their ground - breaking phase 1 DNA - based Zika vaccine research — the first trial of a Zika vaccine in humans, which proved safe and efResearch Achievement Awards by the Clinical Research Forum for their ground - breaking phase 1 DNA - based Zika vaccine research — the first trial of a Zika vaccine in humans, which proved safe and efResearch Forum for their ground - breaking phase 1 DNA - based Zika vaccine research — the first trial of a Zika vaccine in humans, which proved safe and efresearch — the first trial of a Zika vaccine in humans, which proved safe and effective.

The Statens Serum Institut (SSI) Center of Vaccine Research is internationally recognised for its vaccine research and clinical piVaccine Research is internationally recognised for its vaccine research and clinical pResearch is internationally recognised for its vaccine research and clinical pivaccine research and clinical presearch and clinical pipeline.

Old paradigms are rapidly being reworked with virtually no area of vaccine research, vaccine development, clinical trials, vaccine deployment or policy left untouched.

With enthusiasm for cancer immunotherapy mounting thanks to recent successes in the clinic with immune - based cancer treatments such as anti-CTLA-4 and anti-PD-1 antibodies, and the FDA approvals of sipuleucel - T prostate cancer vaccine and ipilimumab for the treatment of melanoma, and in light of the many promising immunotherapies now in clinical trials with potential for near - term FDA approval, the Cancer Research Institute launched the first annual Cancer Immunotherapy Awareness Month in June 2013 as a way to increase public awareness of the power of immunotherapy to revolutionize cancer treatment and of the need for continued public support for research to bring these treatments to more patientsResearch Institute launched the first annual Cancer Immunotherapy Awareness Month in June 2013 as a way to increase public awareness of the power of immunotherapy to revolutionize cancer treatment and of the need for continued public support for research to bring these treatments to more patientsresearch to bring these treatments to more patients sooner.

The clinical research center CAIMED, part of Ponce Health Sciences University in Puerto Rico, will examine the vaccine's safety and immunogenicity in participants who have already been naturally exposed to Zika or dengue viruses

The Pilot Bioproduction Facility at WRAIR manufactured the ZPIV vaccine being used in Phase 1 clinical studies, and the Army recently signed a cooperative research and development agreement to transfer the ZPIV technology to Sanofi Pasteur to explore larger scale manufacturing and advanced development.

Nanotheraputics for Antibiotic Resistent Emerging Bacterial pathogens (NAREB) European Research Infrastructures for Poverty Related Diseases (EURIPED) Biomarkers for enhanced vaccines immunosafety (BioVacSafe) European network of vaccine research and development TRANSVAC Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development (TBResearch Infrastructures for Poverty Related Diseases (EURIPED) Biomarkers for enhanced vaccines immunosafety (BioVacSafe) European network of vaccine research and development TRANSVAC Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development (TBresearch and development TRANSVAC Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development (TBVAC2020)

This experimental vaccine regimen is based on the one tested in the U.S. Military HIV Research Program - led RV144 clinical trial in Thailand — the first study to demonstrate that a vaccine can protect people from HIV infection.

The Transnational Access 1 (TNA1) «Cross platform screening and optimization service «and the corresponding Joint Research Activity (JRA1) «Improved optimization and harmonization of cross-vector screening «will combine the expertise of six different partners (IME, SSI, UOXF, iBET, BPRC and UNISI) to provide the unique offer to test vaccine candidates in a comprehensive range of different expression hosts, to identify the optimal production system for further pre-clinical and clinical development.

David B. Weiner, Ph.D., executive vice president, director of the Vaccine & Immunotherapy Center, and the W.W. Smith Endowed Chair in Cancer Research at The Wistar Institute, and peers received the 2018 Top Ten Clinical Research Achievement Award last night at the National Press Club in Washington, D.C.

The Walter Reed Army Institute of Research (WRAIR) began vaccinations today in a Phase 1 human clinical trial to test the safety and immunogenicity of the Zika purified inactivated virus (ZPIV) vaccine.

According to Col Jerome Kim, Walter Reed Army Institute of Research, US, who was also part of the lead group for the study, apart from the current four doses of vaccines that were given to subjects in the phase III clinical trials in Thailand, they are planning to give a booster does after six months to increase the strength of the vaccine.

Tags: Acute Myeloid Leukemia, Andrew Hsieh, Basic Sciences, Clinical Research, Harmit Malik, Human Biology, Jesse Bloom, Marie Bleakley, Prostate Cancer, Transplant and Immunotherapy, Tumor specific translational research, Vaccine development - ViralResearch, Harmit Malik, Human Biology, Jesse Bloom, Marie Bleakley, Prostate Cancer, Transplant and Immunotherapy, Tumor specific translational research, Vaccine development - Viralresearch, Vaccine development - Viral cancers

Dr. Rabinovich has served in Chief of the Clinical and Regulatory Affairs Branch at the US National Institute of Allergy and Infectious Diseases (NIAID), focusing on the development and evaluation of vaccines through a network of US clinical researcClinical and Regulatory Affairs Branch at the US National Institute of Allergy and Infectious Diseases (NIAID), focusing on the development and evaluation of vaccines through a network of US clinical researcclinical research units.

Therapies applying this paradigm to clear β - amyloid protein (Aβ) plaques and soluble aggregates from patients with Alzheimer's disease (AD) is an extremely active field of research, with multiple active and passive Aβ vaccines currently in human clinical trials.

Tags: Adaptive Biotechnologies, Clinical Research, CMV, Colleen Delaney, Computational Biology, cytomegalovirus, Eddie Mendez, Harlan Robins, head neck cancers, Human Biology, Michael Boeckh, muscular dystrophy, Stephen J Tapscott, tumor paint, Vaccine and Infectious Disease, VIDD

MHRP's international research program has six clinical research sites in the U.S., Africa and Asia, where it conducts HIV cohort studies, HIV vaccine trials and therapeutic studies.

Scientists and vaccine developers involved in EVI projects presented project progress and research findings, highlighting one of the most important areas of EVI's activities; translation of research on diseases of poverty vaccines, focusing on early stages from preclinical to clinical development through harmonisation.

To address this growing problem, NIAID is funding and conducting research on many aspects of antimicrobial (drug) resistance, including basic research on how microbes develop resistance, development of new and faster diagnostics, and clinical trials designed to find new vaccines and treatments effective against drug - resistant microbes.

Tags: aspirin, Bezos, bioengineering, Breast Cancer, Cameron Turtle, Cancer etiology - prevention - outcomes, CAR t - cell, Clinical Research, Colorectal Cancer, genome, hiv, hiv vaccine, hiv vaccine trials network, Human Biology, immunology, Jason Bielas, Lawrence Corey, Matthias Stephan, merkel cell carcinoma, metastasis, Molecular basis of cancer, mylotarg, Obliteride, Paul Nghiem, philanthropy, Polly A Newcomb, Public Health Sciences, RNA, Ruth Etzioni, Soheil Meshinchi, Steven Henikoff, Transplant and Immunotherapy, Tumor specific translational research, Vaccine and Infectious Disease, Vaccine development - ViralResearch, Colorectal Cancer, genome, hiv, hiv vaccine, hiv vaccine trials network, Human Biology, immunology, Jason Bielas, Lawrence Corey, Matthias Stephan, merkel cell carcinoma, metastasis, Molecular basis of cancer, mylotarg, Obliteride, Paul Nghiem, philanthropy, Polly A Newcomb, Public Health Sciences, RNA, Ruth Etzioni, Soheil Meshinchi, Steven Henikoff, Transplant and Immunotherapy, Tumor specific translational research, Vaccine and Infectious Disease, Vaccine development - Viral vaccine, hiv vaccine trials network, Human Biology, immunology, Jason Bielas, Lawrence Corey, Matthias Stephan, merkel cell carcinoma, metastasis, Molecular basis of cancer, mylotarg, Obliteride, Paul Nghiem, philanthropy, Polly A Newcomb, Public Health Sciences, RNA, Ruth Etzioni, Soheil Meshinchi, Steven Henikoff, Transplant and Immunotherapy, Tumor specific translational research, Vaccine and Infectious Disease, Vaccine development - Viral vaccine trials network, Human Biology, immunology, Jason Bielas, Lawrence Corey, Matthias Stephan, merkel cell carcinoma, metastasis, Molecular basis of cancer, mylotarg, Obliteride, Paul Nghiem, philanthropy, Polly A Newcomb, Public Health Sciences, RNA, Ruth Etzioni, Soheil Meshinchi, Steven Henikoff, Transplant and Immunotherapy, Tumor specific translational research, Vaccine and Infectious Disease, Vaccine development - Viralresearch, Vaccine and Infectious Disease, Vaccine development - Viral Vaccine and Infectious Disease, Vaccine development - Viral Vaccine development - Viral cancers

Dr. Merlin Robb, Deputy Director of Clinical Research participated in a panel discussion entitled, «Progress Toward an HIV Vaccine.»

Next steps are correlates research, which is underway, and regional clinical studies, with the goal of developing a globally - effective vaccine.»

In this role, Ms. Roxland re-launched and chaired J&J's Ethics Committee, created an enterprise - wide consultation service for teams and individuals confronting complex research ethics issues, and provided guidance on issues such as post-trial access for former research participants, conducting clinical trials in war - torn regions, testing of a potential Ebola vaccine during a public health crisis, commercialization of stem cell therapies, subject recruitment and withdrawal, and expanded access / compassionate use.

When it conducted this first Ebola vaccine study, MUWRP already had clinical research experience with vaccines and conducted them in accordance with Good Clinical Prclinical research experience with vaccines and conducted them in accordance with Good Clinical PrClinical Practices.